• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    G

    Guru Gobind Singh Medical College and Hospital

    EST. 1973
    646论文总数
    4,023引用总数

    论文量&引用量时间轴

    机构学者

    论文(646)

    年份
    起
    –
    止
    排序
    1Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2025) and Update on Immunization for Children Aged 0 Through 18 Years.
    Digant D. Shastri,Shashi Kant Dhir, B. Rajsekhar, Sumitha Nayak, Chandra Mohan Kumar, Anurag Agarwal, Swapan Kumar Ray, R. Krishna Mohan, Bhadresh R. Vyas, Raman Gangakhedkar,Rajeshwar Dayal, Vijay Bade,

    Recent advancements in vaccinology and the introduction of new vaccines warrant a revision of the existing immunization guidelines. To review and revise the IAP recommendations (2023) on immunization of children aged 0 to 18 years and issue recommendations on existing and new vaccines. The Advisory Committee on Vaccines and Immunization Practices (ACVIP) of the Indian Academy of Pediatrics (IAP) discussed the updates and drafted evidence-based consensus recommendations after several rounds of meetings convened both in-person and virtually. The contents were finalized during the meeting held at the IAP Office, Navi Mumbai, on November 23, 2025. The major changes include recommendation of replacing the quadrivalent (A/H1N1, A/H3N2, B/Victoria, B/Yamagata) influenza vaccines with trivalent (A/H1N1, A/H3N2, B/Victoria) influenza vaccines. The use of nirsevimab for respiratory syncytial virus is recommended for high-risk cases, after consultation with the parents. Immunocompetent girls aged 9 to 15 years may receive a single dose of the human papilloma virus (HPV) vaccine. A 5-dose intramuscular rabies vaccination schedule administered on days 0, 3, 7, 14, and 28 is recommended for post-exposure prophylaxis (PEP), along with rabies immunoglobulin (RIG) or rabies monoclonal antibody (RMAb) based on the category of exposure.

    2026Indian Pediatrics(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Cryotherapy for Keloids Redefined: the Role of Injector Plate in Large Keloid Treatment
    Sumir Kumar, Avneet Kaur, Sameer Kaur
    2026Indian dermatology online journal(2026)
    引用
    AI阅读
    加入学术空间
    3Assessment of Triglyceride Glucose Index in Patients with Nonalcoholic Fatty Liver Disease and Its Correlation with the Disease Severity.
    Tushar Akare,Ravinder Garg, Sumit Pal Singh Chawla, Rashmeet Kaur, Sarabjot Kaur, Shweta Moreshwar Bawankar, Ayush Bansal, Simrat Bhandal

    CONTEXT:Triglyceride (TG) accumulation and insulin resistance (IR) are the hallmarks of nonalcoholic fatty liver disease (NAFLD). The triglyceride glucose (TyG) index may serve as an important risk factor for both hepatic steatosis and liver fibrosis in individuals with NAFLD. AIMS:This study was undertaken to assess the TyG index in patients with NAFLD and to study its correlation with the disease severity. SETTINGS AND DESIGN:This cross-sectional study spanning over 18 months was conducted in the department of Medicine at a tertiary care teaching hospital. MATERIALS AND METHODS:The study enrolled 105 adult NAFLD patients in whom the TyG index was calculated and correlated with serum transaminases and liver elastography measurements. STATISTICAL ANALYSIS USED:Descriptive statistics were calculated for all variables, including mean and standard deviation for continuous variables, and frequency and percentage for categorical variables. Pearson or Spearman correlation coefficients were computed to evaluate the relationships between the TyG index and continuous variables such as liver elastography and transaminases. RESULTS:The mean TyG index was 9.34 ± 0.41. A significant and positive correlation was observed between TyG and liver transaminases (aspartate transaminase: r = 0.53 and alanine transaminase: r = 0.46). The mean liver stiffness measurement (LSM) on liver elastography was 6.04 ± 2.54 kPa. A significant positive correlation was observed between TyG and LSM ( r = 0.71). CONCLUSIONS:TyG is an inexpensive, simple, and easily available surrogate marker of IR, which has statistically significant positive correlation with both serum transaminases and LSM. Thus, TyG may serve as a novel biomarker for predicting disease severity in NAFLD patients.

    2026Annals of African medicine(2026)
    引用
    AI阅读
    加入学术空间
    4Paradoxical Cervical Lymphadenitis During Anti-tubercular Therapy in an Immunocompetent Young Female: A Diagnostic Pitfall
    Ishita Attri, Gunneet Kaur, Rajwinder Dhaliwal, Aakanksha Parik

    A paradoxical reaction (PR) in tuberculosis (TB) is defined as clinical and/or radiological worsening of pre-existing tuberculous lesions or the appearance of new lesions during appropriate anti-tubercular therapy (ATT), despite initial improvement and in the absence of treatment failure, drug resistance, poor adherence, or superinfection. Although more commonly described in HIV-infected or disseminated TB cases, PR can also occur in immunocompetent individuals and may be misinterpreted as disease progression. We report a case of a 19-year-old immunocompetent female receiving standard first-line ATT for sputum-positive pulmonary TB who developed progressive, painless right cervical lymphadenopathy two months after initiation of therapy. Ultrasonography revealed a large necrotic cervical mass suggestive of a tubercular abscess. Repeated ultrasound-guided fine needle aspiration cytology was inconclusive. Given the absence of systemic symptoms, treatment adherence, and lack of evidence of drug resistance, a diagnosis of PR was considered. In conclusion, recognition of PR is essential to prevent unnecessary modification of ATT, escalation to second-line therapy, or invasive procedures. Clinicians should maintain a high index of suspicion for PR in compliant patients presenting with new or enlarging lesions during the early months of treatment.

    2026Cureus(2026)
    引用
    AI阅读
    加入学术空间
    5The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials.
    Martin Cevallos-Cueva,Laura Ghanem, Taissa Novis, Sakshi Arora, Najwaa Kirmani,Sümeyye Aktaş, Esteban Fernández-Faith

    Despite currently available treatment options for moderate-to-severe atopic dermatitis (AD), some patients fail to achieve adequate disease control. Emerging evidence suggests that mesenchymal stem cells (MSCs) may represent a promising therapeutic option. This systematic review and meta-analysis included four randomized controlled trials (RCTs) and one non-randomized clinical trial. Eligible studies evaluated patients with moderate-to-severe AD treated with MSCs derived from human umbilical cord blood, autologous adipose tissue, and allogeneic bone marrow. PubMed, Embase, and Cochrane were searched from inception to December 2025. Primary outcomes included the proportion of patients achieving ≥50% and ≥75% improvement from baseline in the Eczema Area and Severity Index (EASI) and safety outcomes. The meta-analysis included 236 participants. The pooled EASI-50 response rate at week 12 was 46.76% (95% confidence interval [CI]: 32.36% to 61.72%). EASI-75 response rates were 17.41% (95% CI: 5.56% to 43.03%) at week 12 and 23.97% (95% CI: 16.48% to 33.50%) at week 16. The pooled incidence of treatment-emergent adverse events was 26.86% (95% CI: 19.56% to 35.68%), with infections and infestations 7.97% (95% CI: 4.11% to 14.88%) and gastrointestinal disorders 3.52% (95% CI: 1.33% to 9.01%) being the most frequently reported. MSC-based therapy shows early promise as a potential treatment for moderate-to-severe AD, offering a possible alternative to traditional therapies. However, the current evidence is largely based on small clinical trials, underscoring the necessity for large-scale RCTs to establish the efficacy and safety of MSC-based therapy in broader patient populations.

    2026Stem cells and development(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 646 篇论文

    合作机构(100)

    Baba Farid University of Health Sciences合作论文 33
    All India Institute of Medical Sciences合作论文 32
    克什米尔大学合作论文 21
    Dr. Ruth K. M. Pfau Civil Hospital Karachi合作论文 12
    University of Central Punjab合作论文 10
    Dayanand Medical College & Hospital合作论文 9
    Adesh Institute of Medical Sciences & Research合作论文 6
    Liaquat University of Medical & Health Sciences合作论文 6
    Indo Soviet Friendship College of Pharmacy合作论文 6
    上海交通大学合作论文 5

    机构统计